To investigate whether this finding that can distinguish MCC from other skin cancers can be recapitulated in tumor sample biopsies from MCC patients, we performed YTHDF1 immunohistochemistry on tissue microarrays (TMAs) consisting of 31 MCC patients and 26 melanoma patients. Here, YTHDF1 is linked to neoplasm.